| CTRI Number |
CTRI/2026/02/102776 [Registered on: 02/02/2026] Trial Registered Prospectively |
| Last Modified On: |
30/01/2026 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Process of Care Changes |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
Comparison of under-collected and standard blood units for transfusion: A Randomized controlled study |
|
Scientific Title of Study
|
The quality of under collected blood units for transfusion: A Randomized control study |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| 2024-20-PGTH-9 Version 1 dt 14-02-2025 |
Protocol Number |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Amulya Kishan |
| Designation |
MD Student |
| Affiliation |
A.I.I.M.S, Raebareli |
| Address |
Department of Transfusion Medicine, Basement, A.I.I.M.S, Raebareli
Rae Bareli UTTAR PRADESH 229405 India |
| Phone |
8862932845 |
| Fax |
|
| Email |
kishanamulya949@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Trupti Lokhande |
| Designation |
Assistant Professor and Guide |
| Affiliation |
A.I.I.M.S, Raebareli |
| Address |
Room no 441,Fourth floor, Department of Transfusion Medicine, A.I.I.M.S, Raebareli
Rae Bareli UTTAR PRADESH 229405 India |
| Phone |
7877163088 |
| Fax |
|
| Email |
drtrupti.lokhande02@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Trupti Lokhande |
| Designation |
Assistant Professor and Guide |
| Affiliation |
A.I.I.M.S, Raebareli |
| Address |
Room no 441,Fourth floor, Department of Transfusion Medicine, A.I.I.M.S, Raebareli
UTTAR PRADESH 229405 India |
| Phone |
7877163088 |
| Fax |
|
| Email |
drtrupti.lokhande02@gmail.com |
|
|
Source of Monetary or Material Support
|
| A.I.I.M.S., Munshiganj, Raebareli 229405 |
|
|
Primary Sponsor
|
| Name |
Dr Amulya Kishan |
| Address |
Dept of Transfusion Medicine, A.I.I.M.S., Munshiganj, Raebareli |
| Type of Sponsor |
Other [SELF] |
|
|
Details of Secondary Sponsor
|
| Name |
Address |
| Dr Trupti Lokhande |
Room no. 441,Dept of Transfusion Medicine, A.I.I.M.S., Munshiganj, Raebareli |
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Dnyaneshwar Patale |
A.I.I.M.S ,Raebareli |
Dept of Transfusion Medicine Rae Bareli UTTAR PRADESH |
8850112287
dnyaneshwar.patale@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Bioethics cell, All India Institute of Medical Sciences,Raebareli, Uttar Pradesh |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: D649||Anemia, unspecified, (2) ICD-10 Condition: D638||Anemia in other chronic diseases classified elsewhere, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Low volume packed red blood cells |
One unit of Low volume packed red blood cells at a time |
| Comparator Agent |
Standard volume packed red blood cells |
One unit of standard volume packed red blood cells at a time |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
99.00 Year(s) |
| Gender |
Both |
| Details |
1.Adult patient with age more than 18 yrs admitted to Medicine Department, AIIMS Raebareli
2.Indication for PRBC transfusion: Patient with chronic severe anaemia with hemoglobin less than 7gm/dl.
|
|
| ExclusionCriteria |
| Details |
1.Patients with age less than 18 yrs
2.Patients with hemolytic anemia.
3.Patients with more than one unit PRBC transfusion at a time.
4.Patients with chronic severe anemia with hemoglobin more than 7gm/dl.
|
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Centralized |
|
Blinding/Masking
|
Participant and Outcome Assessor Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Hemoglobin (g/dL) of patient |
24 hrs post-transfusion |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| pH of PRBC |
Day 0,7,14,21,28,35,42 or at time of issue if earlier than scheduled time point |
| Hemolysis of PRBC |
Day 0,7,14,21,28,35,42 or at time of issue if earlier than scheduled time point |
|
|
Target Sample Size
|
Total Sample Size="96" Sample Size from India="96"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
02/03/2026 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="9" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Packed red blood cell (PRBC) transfusion is a commonly used treatment for patients with anemia. During routine blood donation, under-collection of whole blood may occur because of donor reactions or technical issues, resulting in under-collected blood units. Although current guidelines allow the use of such units for transfusion, limited evidence is available regarding their quality during storage and their effectiveness in improving hemoglobin levels after transfusion. This randomized controlled trial aims to evaluate the quality of PRBCs prepared from under-collected whole blood units by assessing changes in pH and hemolysis during storage, and to compare post-transfusion hemoglobin increment in anemic adult patients receiving under-collected PRBC units versus standard-volume PRBC units. The findings of this study may help optimize transfusion practices and improve utilization of under-collected blood units without compromising patient safety. |